Crossmark

Evaluation of prophylactic dosages of Enoxaparin in non-surgical elderly patients with renal impairment

Crossref DOI link: https://doi.org/10.1186/s40360-019-0308-8

Published Online: 2019-05-07

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chamoun, Nibal https://orcid.org/0000-0002-0987-296X
Ghanem, Hady

Hachem, Ahmad

Hariri, Essa

Lteif, Christelle

Mansour, Hanine

Dimassi, Hani

Zalloum, Richard

Ghanem, Georges
License Information

Text and Data Mining valid from 2019-05-07
More Information

Article History

Received: 29 January 2019

Accepted: 25 April 2019

First Online: 7 May 2019

Ethics approval and consent to participate

: This study was approved by the Lebanese American University Institutional Review Board (LAU IRB), approval number is LAU.SOP.NC1.25/Jun/2015 and performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Written informed consent was obtained from the patient(s) for their participation and anonymized information to be published in this article.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.